InsidersTradesSigma
Total declarations
Company
▲ Purchases (18 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
18
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-24.5%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Lee Willis C, Chief Executive Officer. Director active across 1 company, notably Emmaus Life Sciences, Inc.. In total, 18 filings have been published. Split: 18 buys · 0 sell. Total volume traded: €63k. History available since 5 May 2021. The latest transaction was filed on 26 February 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Lee Willis C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
13,200 shares@ US$0.121.3% of flowCommon stock, $0.001 par valueSEC:0001209191-24-004124:0
Canonical exit: 26 May 2024 (T+90)
6,500 shares@ US$0.211.1% of flowCommon stock, $0.001 par valueSEC:0001209191-24-000442:0
Canonical exit: 23 Nov 2023 (T+90)
1,365 shares@ US$0.210.2% of flowCommon stock, $0.001 par valueSEC:0001209191-23-057328:0
Canonical exit: 23 Nov 2023 (T+90)
750 shares@ US$0.280.2% of flowCommon stock, $0.001 par valueSEC:0001209191-23-033573:0
Canonical exit: 19 Dec 2022 (T+90)
3,200 shares@ US$0.391.0% of flowCommon stock, $0.001 par valueSEC:0001209191-22-043081:0
Canonical exit: 17 Oct 2022 (T+90)
2,500 shares@ US$0.370.11% mcap0.8% of flowCommon stock, $0.001 par valueSEC:0001209191-22-033847:0
Canonical exit: 25 Aug 2022 (T+90)
3,200 shares@ US$0.980.35% mcap2.5% of flowCommon stock, $0.001 par valueSEC:0001209191-22-024129:0
Canonical exit: 3 Jul 2022 (T+90)
500 shares@ US$1.420.078% mcap0.6% of flowCommon stock, $0.001 par valueSEC:0001209191-22-013725:0
Canonical exit: 23 May 2022 (T+90)
500 shares@ US$1.540.084% mcap0.6% of flowCommon stock, $0.001 par valueSEC:0001209191-22-001426:0
Canonical exit: 3 Mar 2022 (T+90)
24,328 shares@ US$1.4550.2% of flowCommon stock, $0.001 par valueSEC:0001209191-21-067167:0
Canonical exit: 24 Feb 2022 (T+90)
3,500 shares@ US$1.326.6% of flowCommon stock, $0.001 par valueSEC:0001209191-21-066920:0
Canonical exit: 21 Feb 2022 (T+90)
1,600 shares@ US$1.242.8% of flowCommon stock, $0.001 par valueSEC:0001209191-21-066428:0
Canonical exit: 13 Feb 2022 (T+90)
2,000 shares@ US$1.514.1% of flowCommon stock, $0.001 par valueSEC:0001209191-21-056785:0
Canonical exit: 14 Dec 2021 (T+90)
2,000 shares@ US$1.704.6% of flowCommon stock, $0.001 par valueSEC:0001209191-21-055547:0
Canonical exit: 7 Dec 2021 (T+90)
2,400 shares@ US$1.514.9% of flowCommon stock, $0.001 par valueSEC:0001209191-21-053681:0
Canonical exit: 23 Nov 2021 (T+90)
2,700 shares@ US$1.535.4% of flowCommon stock, $0.001 par valueSEC:0001209191-21-036627:0
Canonical exit: 24 Aug 2021 (T+90)
1,500 shares@ US$1.142.2% of flowCommon stock, $0.001 par valueSEC:0001209191-21-032183:0
Canonical exit: 8 Aug 2021 (T+90)
2,500 shares@ US$1.264.2% of flowCommon stock, $0.001 par valueSEC:0001209191-21-030990:0
Canonical exit: 3 Aug 2021 (T+90)
18 of 18 declarations
About Lee Willis C
LEE WILLIS C is Vice-Président et Directeur Général des Opérations. He has 18 filings in total, and across the 18 sampled filings, the transactions are acquisitions for EUR 62694 of purchases and EUR 0 of sales, between 2021-05-07 and 2024-02-29. His filings concern Emmaus Life Sciences, Inc., where he is Co-President & COO.
